These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 26554834)

  • 1. Missense Mutations in LRP5 Associated with High Bone Mass Protect the Mouse Skeleton from Disuse- and Ovariectomy-Induced Osteopenia.
    Niziolek PJ; Bullock W; Warman ML; Robling AG
    PLoS One; 2015; 10(11):e0140775. PubMed ID: 26554834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Bone Mass-Causing Mutant LRP5 Receptors Are Resistant to Endogenous Inhibitors In Vivo.
    Niziolek PJ; MacDonald BT; Kedlaya R; Zhang M; Bellido T; He X; Warman ML; Robling AG
    J Bone Miner Res; 2015 Oct; 30(10):1822-30. PubMed ID: 25808845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of Lrp5 HBM-causing mutations in Cathepsin-K expressing cells alters bone metabolism.
    Kang KS; Hong JM; Horan DJ; Lim KE; Bullock WA; Bruzzaniti A; Hann S; Warman ML; Robling AG
    Bone; 2019 Mar; 120():166-175. PubMed ID: 30409757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanotransduction in bone tissue: The A214V and G171V mutations in Lrp5 enhance load-induced osteogenesis in a surface-selective manner.
    Niziolek PJ; Warman ML; Robling AG
    Bone; 2012 Sep; 51(3):459-65. PubMed ID: 22750014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of multiple bone responses to graded strains above functional levels, and to disuse, in mice in vivo show that the human Lrp5 G171V High Bone Mass mutation increases the osteogenic response to loading but that lack of Lrp5 activity reduces it.
    Saxon LK; Jackson BF; Sugiyama T; Lanyon LE; Price JS
    Bone; 2011 Aug; 49(2):184-93. PubMed ID: 21419885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disuse-related decline in trabecular bone structure.
    Akhter MP; Alvarez GK; Cullen DM; Recker RR
    Biomech Model Mechanobiol; 2011 Jun; 10(3):423-9. PubMed ID: 20683635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone biomechanical properties in LRP5 mutant mice.
    Akhter MP; Wells DJ; Short SJ; Cullen DM; Johnson ML; Haynatzki GR; Babij P; Allen KM; Yaworsky PJ; Bex F; Recker RR
    Bone; 2004 Jul; 35(1):162-9. PubMed ID: 15207752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features, treatment, and follow-up of OPPG and high-bone-mass disorders: LRP5 is a key regulator of bone mass.
    Ren N; Lv S; Li X; Shao C; Wang Z; Mei Y; Yang W; Fu W; Hu Y; Sha L; Hu W; Zhang Z; Wang C
    Osteoporos Int; 2024 Aug; 35(8):1395-1406. PubMed ID: 38625381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New explanation for autosomal dominant high bone mass: Mutation of low-density lipoprotein receptor-related protein 6.
    Whyte MP; McAlister WH; Zhang F; Bijanki VN; Nenninger A; Gottesman GS; Lin EL; Huskey M; Duan S; Dahir K; Mumm S
    Bone; 2019 Oct; 127():228-243. PubMed ID: 31085352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender specific LRP5 influences on trabecular bone structure and strength.
    Dubrow SA; Hruby PM; Akhter MP
    J Musculoskelet Neuronal Interact; 2007; 7(2):166-73. PubMed ID: 17627087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The high-bone-mass phenotype of novel transgenic mice with LRP5 A241T mutation.
    Wang X; Zhang H; Hu L; He J; Jiang Q; Ren L; Yu K; Fu M; Li Z; He Z; Zhu J; Wang Y; Jiang Z; Yang G
    Bone; 2024 Oct; 187():117172. PubMed ID: 38909879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-bone-mass-producing mutations in the Wnt signaling pathway result in distinct skeletal phenotypes.
    Niziolek PJ; Farmer TL; Cui Y; Turner CH; Warman ML; Robling AG
    Bone; 2011 Nov; 49(5):1010-9. PubMed ID: 21855668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High bone mass in mice expressing a mutant LRP5 gene.
    Babij P; Zhao W; Small C; Kharode Y; Yaworsky PJ; Bouxsein ML; Reddy PS; Bodine PV; Robinson JA; Bhat B; Marzolf J; Moran RA; Bex F
    J Bone Miner Res; 2003 Jun; 18(6):960-74. PubMed ID: 12817748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment.
    Sawakami K; Robling AG; Ai M; Pitner ND; Liu D; Warden SJ; Li J; Maye P; Rowe DW; Duncan RL; Warman ML; Turner CH
    J Biol Chem; 2006 Aug; 281(33):23698-711. PubMed ID: 16790443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic mutations and polymorphisms in the lipoprotein receptor-related protein 5 reveal a new biological pathway for the control of bone mass.
    Ferrari SL; Deutsch S; Antonarakis SE
    Curr Opin Lipidol; 2005 Apr; 16(2):207-14. PubMed ID: 15767861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An RNA-seq protocol to identify mRNA expression changes in mouse diaphyseal bone: applications in mice with bone property altering Lrp5 mutations.
    Ayturk UM; Jacobsen CM; Christodoulou DC; Gorham J; Seidman JG; Seidman CE; Robling AG; Warman ML
    J Bone Miner Res; 2013 Oct; 28(10):2081-93. PubMed ID: 23553928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic deletion of low-density lipoprotein receptor-related protein 5 increases cartilage degradation in instability-induced osteoarthritis.
    Lodewyckx L; Luyten FP; Lories RJ
    Rheumatology (Oxford); 2012 Nov; 51(11):1973-8. PubMed ID: 22850184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based mutation analysis shows the importance of LRP5 beta-propeller 1 in modulating Dkk1-mediated inhibition of Wnt signaling.
    Bhat BM; Allen KM; Liu W; Graham J; Morales A; Anisowicz A; Lam HS; McCauley C; Coleburn V; Cain M; Fortier E; Bhat RA; Bex FJ; Yaworsky PJ
    Gene; 2007 Apr; 391(1-2):103-12. PubMed ID: 17276019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The LRP5 high-bone-mass mutation causes alveolar bone accrual with minor craniofacial alteration.
    Turkkahraman H; Flanagan S; Zhu T; Bellido TM; Yuan X
    J Periodontal Res; 2023 Aug; 58(4):723-732. PubMed ID: 37128744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of plasma, serum, and platelet serotonin in individuals with high bone mass and mutations in LRP5.
    Lee GS; Simpson C; Sun BH; Yao C; Foer D; Sullivan B; Matthes S; Alenina N; Belsky J; Bader M; Insogna KL
    J Bone Miner Res; 2014 Apr; 29(4):976-81. PubMed ID: 24038240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.